i.rasmussen
TL2 · Oulu
Contributes reviews on supplier material. Based in Oulu.
Joined 3 December 2024 · last posted 4d · groups: regional-apac
78Posts here
0Topics
0Solutions
233Likes received
180Likes given
15Badges
152Days visited
1.1kPosts read
Recent activity
Full stream-
What a certificate commits its issuer to Replied, post #95 · Analytics › COA interpretation · 24 Jul 2026 · 13 likes Post #93 is the version of this I will quote in future. One addition. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically…
-
Journal club: what we got wrong in an earlier session Replied, post #115 · Evidence › Journal club · 24 Jul 2026 · 0 likes The arithmetic in post #114 is right; the assumption feeding it is the part to check. Reading a preprint in a session is fine provided the status is stated in the first…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #87 · Nutrition & Training › Protein & intake · 21 Jul 2026 · 12 likes The confident answers on Protein density versus volume and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
How shortages have affected compounding permissions Replied, post #49 · Access › Shortages · 18 Jul 2026 · 1 like I read post #47 twice before replying, because I had assumed the opposite. The reason shortages is hard to answer is that the obvious measurement and the relevant…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #59 · Practice › Interactions · 18 Jul 2026 · 2 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Seven-day rolling means and why weekly readings mislead Replied, post #49 · Outcomes › Progress reports · 17 Jul 2026 · 0 likes Everything in post #47 holds. The case it does not cover is the one I have. If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that…
-
Documenting a supplier's response to a discrepancy Replied, post #25 · Sourcing › Vendor reports · 28 Jun 2026 · 4 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Historical amylin analogues and what happened to them Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 22 Jun 2026 · 0 likes Historical amylin analogues: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
-
Prescription portability between countries Replied, post #65 · Access › International · 15 Jun 2026 · 28 likes Worth separating two things that post #63 runs together. An honest declaration on prescription portability between countries: I have a prior here and it is strong…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #12 · Sourcing › Vendor reports · 8 Jun 2026 · 0 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #35 · Analytics › Home & field testing · 31 May 2026 · 6 likes On post #33 — agreed on the reasoning, with one qualification. Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones…
-
Reading a trial's population section before its results Replied, post #44 · Evidence › Trials · 22 May 2026 · 5 likes A trial that answers a slightly different question from the one you have is the normal situation rather than a failure of the trial. The skill is describing the gap…